MedPath

CNW FAR EAST LIMITED

🇭🇰Hong Kong, China
Ownership
-
Employees
-
Market Cap
-
Website

Clinical Trials

0

Active:0
Completed:0

Trial Phases

0 Phases

Drug Approvals

15

PPB:15

Drug Approvals

NALOREX FILM-COATED TABLETS 50MG

Approval Date
Dec 8, 2014
PPB

NALTREXONE HYDROCHLORIDE TAB 50MG (ISTITUTO DE ANGELI SRL)

Approval Date
Dec 30, 2009
PPB

ECOMI DERMATOLOGIC CREAM 1%

Approval Date
Jul 28, 2009
PPB

FOLICIL TAB 5MG

Approval Date
Jun 10, 2003
PPB

BETA-SYNTO TAB 8MG

Approval Date
May 16, 2002
PPB

NIMM TAB 100MG

Approval Date
Aug 24, 2001
PPB

SYNTOCLAV FOR SUSP. 156.25MG/5ML

Approval Date
Oct 27, 2000
PPB

SYNTOCLAV 625 TAB (FILM COATED)

Approval Date
Oct 27, 2000
PPB

SYNTOCLAV FORTE FOR SUSP. 312.5MG/5ML

Approval Date
Oct 27, 2000
PPB

SYNTOCLAV 375 TAB (FILM COATED)

Approval Date
Oct 27, 2000
PPB
  • Prev
  • 1
  • 2
  • Next

Clinical Trials

No trials found

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.